NAV
$49.53
AUM
$13.4B
Expense Ratio
-
Dividend Yield
2.41%
Beta
0.86
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +9.13% | +2.93% | +5.89% | +15.83% | +14.58% | +7.83% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 5.46% |
| 2 | ALV.DE | Allianz SE | 2.47% |
| 3 | ABBN.SW | ABB Ltd | 2.17% |
| 4 | ROP.SW | Roche Holding AG Ordinary Shares new | 2.17% |
| 5 | NESN.SW | Nestle SA | 1.89% |
| 6 | AZN.L | AstraZeneca PLC | 1.89% |
| 7 | NOVN.SW | Novartis AG Registered Shares | 1.77% |
| 8 | ZURN.SW | Zurich Insurance Group AG | 1.75% |
| 9 | BHP.AX | BHP Group Ltd | 1.63% |
| 10 | SHEL.L | Shell PLC | 1.50% |
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index measures the performance of international developed large- and mid-capitalization stocks exhibiting relatively higher quality characteristics as identified through three fundamental variables: return on equity, earnings variability and debt-to-equity.
Inception Date: 2015-01-13